IL1B and depressive symptom measurement: Available research demonstrates that schizophrenia and depression both have shown increased rates of cytokines, including IL-1β, IL-6, and TNF-α, which indicate systemic inflammation followed by cognitive impairment, treatment unresponsiveness, and disturbances in mood [6].